Research Paper Volume 15, Issue 17 pp 9086—9104
Integrated clustering signature of genomic heterogeneity, stemness and tumor microenvironment predicts glioma prognosis and immunotherapy response
Figure 9. Analysis of risk signature in immunotherapy cohort and pan cancer. (A) Violin plot depicting the risk scores between SD/PD and CR/PR groups in the IMVIgor210 cohort. (B) The response rate of the high-risk score group and low-risk score group to immune therapy in the IMVIgor210 cohort. (C) Survival analysis of patients with low-risk scores and high-risk scores in the IMVIgor210 cohort. (D) Survival analysis of 3 risk hub genes in pan cancer. (E) Kaplan-Meier survival curve of patients in high- and low-risk score groups in pan cancer. **, P < 0.01.